SCHEMBL5818673

SCHEMBL5818673

COc1ccc(-c2nc(N3CCN(C(=O)OC(C)(C)C)CC3)sc2-c2ccnc(NC3CCCCC3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
ALOX5 P09917 1/20 0.45
KMT2A Q03164 2/20 0.44
DYRK1A Q13627 1/20 0.42
DGAT1 O75907 2/20 0.42
HTT P42858 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
CDK1 P06493 2/20 0.40
CDK4 P11802 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNA2 P20248 2/20 0.40
CCND1 P24385 2/20 0.40
CDK2 P24941 2/20 0.40
CCND3 P30281 2/20 0.40
CDK7 P50613 2/20 0.40
CCNH P51946 2/20 0.40
CDK6 Q00534 2/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819074 0.99 ALDH1A1 (0.47) ALDH1A1ALOX5KMT2ADYRK1ADGAT1
SCHEMBL5813636 0.96 ALDH1A1 (0.48) ALDH1A1ALOX5KMT2ADYRK1ADGAT1
SCHEMBL5812813 0.92 KCNH2 (0.47) ALOX5DGAT1CDK1CDK4CCNB1
SCHEMBL5817854 0.91 KCNH2 (0.48) ALOX5DGAT1CDK1CDK4CCNB1
SCHEMBL5812944 0.88 KCNH2 (0.47) CDK2
SCHEMBL5815226 0.87 KMT2A (0.50) ALDH1A1ALOX5KMT2AHTTNPSR1
SCHEMBL5819436 0.87 ALDH1A1 (0.43) ALDH1A1ALOX5KMT2ADYRK1ADGAT1
SCHEMBL5818666 0.87 MAPK14 (0.43) ALOX5KMT2ADGAT1GPR119CDK1
SCHEMBL5818777 0.86 KMT2A (0.60) ALDH1A1KMT2ACDK1CDK4CCNB1
SCHEMBL5818376 0.86 BRAF (0.46) ALOX5DGAT1CDK1CDK4CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed